Skip to main content
. 2017 Jul 5;7:4637. doi: 10.1038/s41598-017-04113-w

Figure 7.

Figure 7

Linc-ROR acts as a ceRNA for ZEB2 by releasing miR-145 in HCC cells. (A) qRT-PCR and Western blotting assays were performed to detect the mRNA and protein levels of ZEB2 after cells transfected with linc-ROR and miR-145/mimics. **p < 0.01 vs. Vector group; ##p < 0.01 vs. linc-ROR + miR-NC/mimics group. (B) qRT-PCR and Western blotting assays were performed to detect the mRNA and protein levels of ZEB2 after cells transfected with shROR and miR-145/inhibitor. **p < 0.01 vs. shCtrl group; ##p < 0.01 vs. shROR + miR-NC/inhibitor group. (C) qRT-PCR detection of miR-145 expression in HCC and adjacent nontumor liver tissues (p < 0.01), showing negative correlation between linc-ROR and miR-145 expression levels in HCC tissues (Spearman’s correlation, r = −0.716, p < 0.01). (D) The expression of ZEB2 in paired samples of primary HCC and adjacent nontumor liver tissues, showing positive correlation between ROR expression and ZEB2 expression in HCC tissues (Spearman’s correlation, r = 0.804, p < 0.01). (E) Schematic overview of linc-ROR regulatory signaling. T: HCC tissues; N: nontumor liver tissues. Data are presented as mean ± SD from three independent experiments. ***p < 0.001.